Stay updated on Ixekizumab for Bullous Pemphigoid Clinical Trial

Sign up to get notified when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixekizumab for Bullous Pemphigoid Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now displayed on the page, replacing Revision: v3.5.3. This indicates a deployment version update of the site interface rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-05-16T08:36:57.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a display/version change rather than any update to the clinical trial study details.
    Difference
    0.1%
    Check dated 2026-04-24T17:09:09.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:00:41.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Added Pemphigoid as a keyword and updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:50:53.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the previous v3.4.2 entry on the site.
    Difference
    0.1%
    Check dated 2026-03-12T21:29:19.000Z thumbnail image
  9. Check
    112 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 and no longer shows Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T01:53:54.000Z thumbnail image

Stay in the know with updates to Ixekizumab for Bullous Pemphigoid Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.